# Caleres Inc: overview

CAL · NYSE · CIK 14707 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/cal.md) · [Financials](/companies/cal/financials.md) · [Filings](/companies/cal/filings.md) · [Insiders](/companies/cal/insiders.md)

Latest reported revenue: [$695.5m](/filings/0000014707-26-000144.md) for Q2 FY2026, three months to 2026-08-01, from the 10-Q filed Sep 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0000014707-26-000144).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [741](/filings/0000014707-25-000086.md) | [639 d](/filings/0000014707-26-000053.md) | [614](/filings/0000014707-26-000087.md) | [659](/filings/0000014707-26-000144.md) | [790](/filings/0000014707-25-000086.md) | [695 d](/filings/0000014707-26-000053.md) | [667](/filings/0000014707-26-000087.md) | [695](/filings/0000014707-26-000144.md) |
| Gross margin | % | [44.1%](/filings/0000014707-25-000086.md) | [43.0% d](/filings/0000014707-26-000053.md) | [45.4%](/filings/0000014707-26-000087.md) | [43.4%](/filings/0000014707-26-000144.md) | [41.8%](/filings/0000014707-25-000086.md) | [41.8% d](/filings/0000014707-26-000053.md) | [47.3%](/filings/0000014707-26-000087.md) | [54.8%](/filings/0000014707-26-000144.md) |
| Operating margin | % | [7.7%](/filings/0000014707-25-000086.md) | [1.2% d](/filings/0000014707-26-000053.md) | [1.9%](/filings/0000014707-26-000087.md) | [1.4%](/filings/0000014707-26-000144.md) | [1.5%](/filings/0000014707-25-000086.md) | [(3.8%) d](/filings/0000014707-26-000053.md) | [3.6%](/filings/0000014707-26-000087.md) | [11.2%](/filings/0000014707-26-000144.md) |
| Net margin | % | [5.6%](/filings/0000014707-25-000086.md) | [0.8% d](/filings/0000014707-26-000053.md) | [1.1%](/filings/0000014707-26-000087.md) | [1.0%](/filings/0000014707-26-000144.md) | [0.3%](/filings/0000014707-25-000086.md) | [(3.3%) d](/filings/0000014707-26-000053.md) | [2.1%](/filings/0000014707-26-000087.md) | [8.4%](/filings/0000014707-26-000144.md) |
| Diluted EPS | $ per share | [1.19](/filings/0000014707-25-000086.md) | not reported | [0.21](/filings/0000014707-26-000087.md) | [0.20](/filings/0000014707-26-000144.md) | [0.07](/filings/0000014707-25-000086.md) | not reported | [0.42](/filings/0000014707-26-000087.md) | [1.71](/filings/0000014707-26-000144.md) |
| Free cash flow | $m | [(57.4) d](/filings/0000014707-25-000086.md) | [18.0 d](/filings/0000014707-26-000053.md) | [(26.2)](/filings/0000014707-26-000087.md) | [35.0 d](/filings/0000014707-26-000144.md) | [(12.4) d](/filings/0000014707-25-000086.md) | [43.1 d](/filings/0000014707-26-000053.md) | [(39.0)](/filings/0000014707-26-000087.md) | [75.6 d](/filings/0000014707-26-000144.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-29) | FY2022 (2023-01-28) | FY2023 (2024-02-03) | FY2024 (2025-02-01) | FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,778](/filings/0000014707-24-000012.md) | [2,968](/filings/0000014707-25-000017.md) | [2,817](/filings/0000014707-26-000053.md) | [2,723](/filings/0000014707-26-000053.md) | [2,758](/filings/0000014707-26-000053.md) |
| Gross margin | % | [44.2%](/filings/0000014707-24-000012.md) | [43.3%](/filings/0000014707-25-000017.md) | [44.8%](/filings/0000014707-26-000053.md) | [44.9%](/filings/0000014707-26-000053.md) | [43.0%](/filings/0000014707-26-000053.md) |
| Operating margin | % | [7.4%](/filings/0000014707-24-000012.md) | [7.2%](/filings/0000014707-25-000017.md) | [6.9%](/filings/0000014707-26-000053.md) | [5.5%](/filings/0000014707-26-000053.md) | [0.2%](/filings/0000014707-26-000053.md) |
| Net margin | % | [4.9%](/filings/0000014707-24-000012.md) | [6.1%](/filings/0000014707-25-000017.md) | [6.1%](/filings/0000014707-26-000053.md) | [3.9%](/filings/0000014707-26-000053.md) | [(0.2%)](/filings/0000014707-26-000053.md) |
| Diluted EPS | $ per share | [3.56](/filings/0000014707-24-000012.md) | [4.92](/filings/0000014707-25-000017.md) | [4.80](/filings/0000014707-26-000053.md) | [3.09](/filings/0000014707-26-000053.md) | [(0.21)](/filings/0000014707-26-000053.md) |
| Free cash flow | $m | [150](/filings/0000014707-24-000012.md) | [70.0](/filings/0000014707-25-000017.md) | [156](/filings/0000014707-26-000053.md) | [55.4](/filings/0000014707-26-000053.md) | [39.4](/filings/0000014707-26-000053.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cal/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $62.3m | 5,038,461 |  | Reduced −45,873 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $48.9m | 3,950,701 |  | Added +1,022,708 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.8m | 1,436,038 |  | Reduced −36,501 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $16.3m | 1,319,034 |  | Added +111,486 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $15.7m | 1,268,543 |  | Added +128,268 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $15.6m | 1,259,784 |  | Reduced −185,116 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $12.7m | 1,023,400 |  | Reduced −27,346 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $11.3m | 917,007 |  | Reduced −557,664 |
| [Invenomic Capital Management LP](/funds/1769456.md) | 2026-06-30 | $11.2m | 902,633 |  | Reduced −201,380 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $11.1m | 900,821 |  | Reduced −122,158 |

## Recent filings

[All 1,428 filings](/companies/cal/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-10 | 07:48 ET | [10-Q](/filings/0000014707-26-000144.md) | Quarterly report, period 2026-08-01 | 0000014707-26-000144 |
| 2026-09-09 | 07:49 ET | [8-K](/filings/0000014707-26-000138.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000014707-26-000138 |
| 2026-06-09 | 16:03 ET | [10-Q](/filings/0000014707-26-000087.md) | Quarterly report, period 2026-05-02 | 0000014707-26-000087 |
| 2026-06-04 | 08:37 ET | [8-K](/filings/0000014707-26-000080.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000014707-26-000080 |
| 2026-05-28 | 17:22 ET | [8-K](/filings/0000014707-26-000070.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000014707-26-000070 |
| 2026-05-20 | 07:55 ET | [8-K](/filings/0000014707-26-000062.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000014707-26-000062 |
| 2026-04-16 | 15:25 ET | [DEF 14A](/filings/0001193125-26-158809.md) | Proxy statement, period 2026-05-28 | 0001193125-26-158809 |
| 2026-04-02 | 17:26 ET | [10-K](/filings/0000014707-26-000053.md) | Annual report, period 2026-01-31 | 0000014707-26-000053 |
| 2026-03-19 | 08:49 ET | [8-K](/filings/0000014707-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000014707-26-000039 |
| 2026-01-22 | 17:54 ET | [8-K](/filings/0000014707-26-000006.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014707-26-000006 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0000014707-26-000053.md), filed Apr 2, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 14707
- Tickers: CAL
- Exchange: NYSE
- SIC code: 3140 Footwear, (No Rubber)
- State of incorporation: NY
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.